Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Oncology Nutrition Market

Oncology Nutrition Market Share

Report ID: GMI9015
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Oncology Nutrition Market Share

The competitive landscape of the market is characterized by the presence of established pharmaceutical and nutraceutical companies that manufacture nutritional products vying for market share. Key players are engaging in strategic initiatives such as acquisitions, product launch, investment, and partnerships to strengthen their product portfolio.

Oncology Nutrition Market Companies

Prominent players operating in the market are as mentioned below:

Abbott Laboratories
Baxter International Inc.
B. Braun Melsungen AG
Danone (Nutricia)
Fresenius SE & Co. KGaA
Grifol S.A.
Hormel Foods Corporation
Meiji Holdings Co., Ltd.
Medtrition Inc.
Nestle S.A.
Victus, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Oncology nutrition industry size recorded USD 2.1 billion in 2023 and is expected to register 8.1% CAGR from 2024 to 2032, due to the rising global prevalence of cancer.

The stomach and gastrointestinal cancer segment in the market accounted for USD 472 million in revenue in 2023, owing to poor dietary habits like high consumption of processed foods, red meats, and low intake of fruits and vegetables.

North America oncology nutrition industry held 42.7% revenue share in 2023 and is expected to depict substantial growth from 2024 to 2032, led by the increasing prevalence of cancer and the growing number of cancer survivors.

Abbott Laboratories, Baxter International Inc., B. Braun Melsungen AG, Danone (Nutricia), Fresenius SE & Co. KGaA, Grifol S.A., Hormel Foods Corporation, Meiji Holdings Co., Ltd., Medtrition Inc., Nestle S.A., and Victus, Inc. are some of the major oncology nutrition companies worldwide.